Bio-Rad Acquires Hematronix

In a move that will add to the company's portfolio of quality control products, Bio-Rad Laboratories, Inc. (Hercules, CA, USA), has purchased the assets of Hematronix, Inc. (Plano, TX, USA). Terms were not disclosed.

Bio-Rad will maintain the operations of Hematronix in Plano (TX, USA) while research and development, manufacturing, and distribution activities will continue in Benicia (CA, USA). Hematronix supplies quality control and quality assurance products and services to the clinical diagnostic industry. The company manufactures a full line of hematology and urine controls, hematology reagents, and regulatory products and services.

Bio-Rad is a multinational manufacturer and distributor of life science research products and clinical diagnostics. The company offers a broad selection of quality control products that enable clinical laboratories to provide consistent and reliable patient-testing results. Products include controls for hundreds of diagnostic analytes, data-management software, and Internet-based programs for quality control data reporting.

"This acquisition further enhances our leadership position in the area of quality control products that are integral to the accurate diagnosis of a wide variety of maladies,” said Norman Schwartz, president and CEO of Bio-Rad.




Related Links:
Bio-Rad
Hematronix